Los Angeles Capital Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-409,938
| Closed | -$255K | – | 1327 |
|
|
2025
Q1 | $255K | Buy |
409,938
+108,519
| +36% | +$67.6K | ﹤0.01% | 944 |
|
|
2024
Q4 | $503K | Buy |
301,419
+43,640
| +17% | +$72.9K | ﹤0.01% | 812 |
|
|
2024
Q3 | $469K | Buy |
+257,779
| New | +$469K | ﹤0.01% | 878 |
|
|
2024
Q2 | – | Sell |
-98,960
| Closed | -$1.1M | – | 1168 |
|
|
2024
Q1 | $1.1M | Sell |
98,960
-24,460
| -20% | -$273K | ﹤0.01% | 666 |
|
|
2023
Q4 | $1.84M | Sell |
123,420
-23,257
| -16% | -$346K | 0.01% | 498 |
|
|
2023
Q3 | $704K | Hold |
146,677
| – | – | ﹤0.01% | 748 |
|
|
2023
Q2 | $1.1M | Buy |
146,677
+3,170
| +2% | +$23.8K | ﹤0.01% | 631 |
|
|
2023
Q1 | $649K | Sell |
143,507
-6,425
| -4% | -$29K | ﹤0.01% | 781 |
|
|
2022
Q4 | $1.69M | Sell |
149,932
-1,180
| -0.8% | -$13.3K | 0.01% | 557 |
|
|
2022
Q3 | $1.45M | Buy |
151,112
+52,148
| +53% | +$499K | 0.01% | 588 |
|
|
2022
Q2 | $801K | Buy |
+98,964
| New | +$801K | ﹤0.01% | 800 |
|
|
2021
Q4 | – | Sell |
-3,979
| Closed | -$294K | – | 1385 |
|
|
2021
Q3 | $294K | Buy |
+3,979
| New | +$294K | ﹤0.01% | 1316 |
|